This year brought with it a wave of interesting issues in the health law arena—be it questions of limiting health care access to immigrants, the ongoing challenges of the opioid epidemic, or the ever-changing landscape of drug pricing.
Join us next week as we unpack the major health law developments of 2019 and discuss what to watch for in the year to come. Over the course of the day, leading experts will consider hot topic issues such as, health policy under the current administration, pharmaceutical policy, and global health. Featured panel discussions include “Challenges Facing Health Care General Counsels” and “AI in Health Care.”
In addition to panel discussions and speaker presentations, the conference will feature a special Fireside Chat between Glenn Cohen and Stacy Cline Amin, who serves as Chief Counsel of the Food and Drug Administration and Deputy General Counsel of the Department of Health and Human Services. She previously served as Special Assistant to the President and Senior Associate Counsel to the President, serving as the senior legal advisor on matters relating to the Department of Health and Human Services. Stacy will offer a window into what 2019 holds for the FDA.
This event is free and open to the public, but seating is limited and registration is required. Register now!
The Seventh Annual Health Law Year in P/Review is sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund at Harvard University.
The post FDA General Counsel Stacy Cline Amin at HLS Next Week appeared first on Bill of Health.